SS Innovations CEO Unveils Strategy for Affordable Robotic Surgery

In a recent Medsider interview, Dr. Sudhir Srivastava, founder, chairman and CEO of SS Innovations International (NASDAQ: SSII), detailed the company’s strategy to democratize robotic surgery through affordability, accessibility, and cutting-edge technology. SS Innovations, a developer of innovative surgical robotic technologies, is focusing on lowering costs and expanding training to bring robotic surgery to hospitals and patients who have historically been excluded due to high equipment expenses. The company’s SSi Mantra system is designed to reduce the cost of robotic surgery while supporting multiple specialties, including cardiac surgery. Artificial intelligence, automation, and new robotic platforms remain central to the company’s long-term product roadmap, with telesurgery and teleproctoring emerging as key differentiators that allow expert surgeons to support complex procedures remotely.

SS Innovations has already installed more than 200 robotic systems and completed over 11,700 robotic procedures, including more than 170 telesurgeries. The company is actively pursuing FDA and European regulatory approvals while expanding into additional international markets. Rather than directly competing with existing robotic surgery platforms, Dr. Srivastava emphasized the goal of broadening access to robotic surgery globally. The interview, originally published on NEWMEDIAWIRE, highlights how SS Innovations is positioning itself as a leader in affordable surgical robotics. For investors evaluating emerging medical technology companies, understanding the competitive advantages behind a product is as important as financial results, and SS Innovations’ focus on cost reduction and remote capabilities sets it apart.

The company’s forward-looking statements, as detailed in the release, underscore the risks and uncertainties inherent in such ventures, including various factors beyond management’s control. However, SS Innovations’ track record and strategic direction suggest a strong potential for growth in the surgical robotics market. With a commitment to making robotic surgery more accessible, the company is poised to transform the landscape of minimally invasive procedures. For more details, readers can access the full Read More article.